Johnson & Johnson's experimental prostate cancer drug, JNJ-6143, has shown significant tumor shrinkage and reduced PSA levels ...

Zymeworks has entered a global licensing agreement with Roche to develop and commercialize its experimental lung cancer drug ...

A groundbreaking study reveals that Amgen's Imdelltra, when combined with AstraZeneca's immunotherapy Imfinzi, significantly ...

AstraZeneca's late-stage trial data reveals significant improvements in overall survival for advanced stomach cancer patients using the drug sone-ve, outperforming chemotherapy and raising potential ...

Biocon has secured a license to introduce its Stelara biosimilar in nine additional countries, expanding treatment access for ...

Roche's investigational cancer drug divarasib significantly lowers the risk of death for patients with KRAS G12C-mutated ...

Takeda Pharmaceutical aims for regulatory approval in Japan for its promising gastric cancer drug, TAK-921, following ...

The inclusion of Dr. Naresh Trehan in a pharmaceutical marketing review panel faces backlash from patient groups over ...

Dr Reddy's Laboratories has introduced two new generic versions of Ozempic, named Obeda Pro and Obeda Plus, to address supply ...

AbbVie announced promising results for its experimental drug lutikizumab in reducing skin lesions from hidradenitis ...

Telitacicept met the study's main goal and largely preserved kidney function over two years, while patients on placebo saw a ...

The deal follows positive mid-stage results for Gilead's experimental pill for chronic bowel disease, emvistegrast, on Monday ...